You are not currently logged in.
Access JSTOR through your library or other institution:
Contribution of Human α-Defensin 1, 2, and 3 to the Anti-HIV-1 Activity of CD8 Antiviral Factor
Linqi Zhang, Wenjie Yu, Tian He, Jian Yu, Rebecca E. Caffrey, Enrique A. Dalmasso, Siyu Fu, Thang Pham, Jianfeng Mei, Jaclyn J. Ho, Wenyong Zhang, Peter Lopez and David D. Ho
New Series, Vol. 298, No. 5595 (Nov. 1, 2002), pp. 995-1000
Published by: American Association for the Advancement of Science
Stable URL: http://www.jstor.org/stable/3832892
Page Count: 6
You can always find the topics here!Topics: T lymphocytes, HIV 1, Antibodies, Antivirals, Viruses, Neutrophils, Molecules, Disulfides, Infections, Cultured cells
Were these topics helpful?See somethings inaccurate? Let us know!
Select the topics that are inaccurate.
Preview not available
It has been known since 1986 that CD8 T lymphocytes from certain HIV-1-infected individuals who are immunologically stable secrete a soluble factor, termed CAF, that suppresses HIV-1 replication. However, the identity of CAF remained elusive despite an extensive search. By means of a protein-chip technology, we identified a cluster of proteins that were secreted when CD8 T cells from long-term nonprogressors with HIV-1 infection were stimulated. These proteins were identified as α-defensin 1, 2, and 3 on the basis of specific antibody recognition and amino acid sequencing. CAF activity was eliminated or neutralized by an antibody specific for human α-defensins. Synthetic and purified preparations of α-defensins also inhibited the replication of HIV-1 isolates in vitro. Taken together, our results indicate that α-defensin 1, 2, and 3 collectively account for much of the anti-HIV-1 activity of CAF that is not attributable to β-chemokines.
Science © 2002 American Association for the Advancement of Science